Treatment Action Group and the 1/4/6x24 Campaign Coalition launch the 1/4/6x24 World TB Day Toolkit to support advocacy the week of World TB Day for access to shorter, safer regimens for TB prevention and treatment.

TAG applauds Molbio’s agreement with the Stop TB Partnership, USAID, and the Global Fund to reduce the price of Truenat diagnostics for TB from US$9 per test to $7.90 per test and to provide quality service and maintenance of Truenat testing instruments globally.

Treatment Action Group (TAG) released an overview of TB research data reported at the 30th Conference on Retroviruses and Opportunistic Infections (CROI 2023) held on 19-22 February 2023 in Seattle, Washington, USA. Highlights include the much-anticipated results of the SimpliciTB trial; additional analyses of the two-month TB treatment regimen studied in the TRUNCATE-TB trial; and the first clinical trial data on sutezolid since 2012.

Tuesday, March 14, 2023
8:00 am – 9:30 am ET

Treatment Action Group launches the 2022 Tuberculosis Treatment Pipeline Report.

A few recent Campaign updates from Treatment Action Group and allies.
Contact david.branigan@treatmentactiongroup.org for more information on how to be part of the 1/4/6x24 Campaign.

A report highlights that despite reaching US$1 billion in spending in 2021, funding for TB R&D is a mere fraction of what’s needed to achieve UN sustainable development goal of ending TB as a pandemic by 2030.

Statement by Treatment Action Group (TAG) and the Global Tuberculosis Community Advisory Board (TB CAB)

Materials designed to equip civil society and community-based organizations with the information they need to advocate for equitable access to the short-course treatment and prevention regimens at the heart of the 1/4/6×24 Campaign.

Treatment Action Group launches the 2022 Tuberculosis Diagnostics Pipeline Report.